315 related articles for article (PubMed ID: 12903021)
1. Radiation-induced lung injury.
Marks LB; Yu X; Vujaskovic Z; Small W; Folz R; Anscher MS
Semin Radiat Oncol; 2003 Jul; 13(3):333-45. PubMed ID: 12903021
[TBL] [Abstract][Full Text] [Related]
2. [The relevance of cytokines in the radiation-induced lung reaction. Experimental basis and clinical significance].
Rübe CE; Rodemann HP; Rübe C
Strahlenther Onkol; 2004 Sep; 180(9):541-9. PubMed ID: 15378184
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
[TBL] [Abstract][Full Text] [Related]
4. [Radiogenic lung reactions. Pathogenesis--prevention--therapy].
Herrmann T; Knorr A
Strahlenther Onkol; 1995 Sep; 171(9):490-8. PubMed ID: 7570298
[TBL] [Abstract][Full Text] [Related]
5. A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer.
Miller KL; Shafman TD; Marks LB
Semin Radiat Oncol; 2004 Oct; 14(4):298-307. PubMed ID: 15558504
[TBL] [Abstract][Full Text] [Related]
6. Small molecular inhibitor of transforming growth factor-beta protects against development of radiation-induced lung injury.
Anscher MS; Thrasher B; Zgonjanin L; Rabbani ZN; Corbley MJ; Fu K; Sun L; Lee WC; Ling LE; Vujaskovic Z
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):829-37. PubMed ID: 18411002
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced lung injury. Assessment, management, and prevention.
Ghafoori P; Marks LB; Vujaskovic Z; Kelsey CR
Oncology (Williston Park); 2008 Jan; 22(1):37-47; discussion 52-3. PubMed ID: 18251282
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric and clinical predictors for radiation-induced esophageal injury.
Ahn SJ; Kahn D; Zhou S; Yu X; Hollis D; Shafman TD; Marks LB
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):335-47. PubMed ID: 15667951
[TBL] [Abstract][Full Text] [Related]
9. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models.
Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G
Radiother Oncol; 2007 Mar; 82(3):308-16. PubMed ID: 17224197
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary toxicity of drugs and thoracic irradiation in children].
Fauroux B; Clément A; Tournier G
Rev Mal Respir; 1996 Jul; 13(3):235-42. PubMed ID: 8765915
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary complications of cancer therapy.
Wesselius LJ
Compr Ther; 1992 Mar; 18(3):17-20. PubMed ID: 1572146
[TBL] [Abstract][Full Text] [Related]
12. Radiation esophagitis: Predictive factors and preventive strategies.
Bradley J; Movsas B
Semin Radiat Oncol; 2004 Oct; 14(4):280-6. PubMed ID: 15558501
[TBL] [Abstract][Full Text] [Related]
13. Prevention of acute radiation-induced esophagitis with glutamine in non-small cell lung cancer patients treated with radiotherapy: evaluation of clinical and dosimetric parameters.
Topkan E; Yavuz MN; Onal C; Yavuz AA
Lung Cancer; 2009 Mar; 63(3):393-9. PubMed ID: 18691789
[TBL] [Abstract][Full Text] [Related]
14. Open label multicenter trial of subcutaneous amifostine (Ethyol) in the prevention of radiation induced esophagitis and pneumonitis in patients with measurable, unresectable non-small cell lung cancer.
Mehta V
Semin Oncol; 2004 Dec; 31(6 Suppl 18):42-6. PubMed ID: 15726522
[TBL] [Abstract][Full Text] [Related]
15. Complications of thoracic radiotherapy.
Chargari C; Riet F; Mazevet M; Morel E; Lepechoux C; Deutsch E
Presse Med; 2013 Sep; 42(9 Pt 2):e342-51. PubMed ID: 23972736
[TBL] [Abstract][Full Text] [Related]
16. The role of radiation therapy in thoracic tumors.
Kong FM; Zhao L; Hayman JA
Hematol Oncol Clin North Am; 2006 Apr; 20(2):363-400. PubMed ID: 16730299
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
Lee EK; Fox T; Crocker I
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
[TBL] [Abstract][Full Text] [Related]
18. Using biological markers to predict risk of radiation injury.
Fleckenstein K; Gauter-Fleckenstein B; Jackson IL; Rabbani Z; Anscher M; Vujaskovic Z
Semin Radiat Oncol; 2007 Apr; 17(2):89-98. PubMed ID: 17395039
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.
Liu HH; Wang X; Dong L; Wu Q; Liao Z; Stevens CW; Guerrero TM; Komaki R; Cox JD; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1268-79. PubMed ID: 15001272
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
